DrugDashboards

Childrens Allergy

fexofenadine hydrochloride · FEXOFENADINE HYDROCHLORIDE 30 mg/5mL · Suspension · Oral · H2-Pharma, LLC

NDC 61269-0527-94 · 1 BOTTLE in 1 CARTON / 118 mL in 1 BOTTLE · ANDA · View full market →

The short version

5 companies supply this market — a reasonable cushion if one runs into trouble. The price has jumped 89% in a year, to $0.1174 per mL — sharp rises like this often mean supply is already tightening. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want. Historically, drugs in this position went on to a new shortage within 90 days about 0.3% of the time — roughly 2× the typical drug (0.1%).

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.05$0.1$0.15Apr 2024Sep 2026$0.1174
30 price points · per MLSource: CMS NADAC

Estimated fill cost

WAC per package, as filed
$7.82
Reported to Texas DSHS · 2025 annual filing · H2-Pharma, LLC

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$125,789
7,771 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

5Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • 5 active manufacturers+5

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.3%chance of a new FDA shortage posting for fexofenadine hydrochloride (other) in the next 90 days

price up 92% YoY · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is 2× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
ANDA203330
TE code
Approval date
Nov 18, 2014
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of fexofenadine hydrochloride (Suspension)

LabelerStrengthFirst seenLast seen
Chattem, Inc.FEXOFENADINE HYDROCHLORIDE 30 mg/5mLJul 15, 2026Sep 3, 2026
H2-Pharma, LLCFEXOFENADINE HYDROCHLORIDE 30 mg/5mLJul 15, 2026Sep 2, 2026
Sun Pharmaceutical Industries, Inc.FEXOFENADINE HYDROCHLORIDE 30 mg/5mLJul 15, 2026Sep 2, 2026
Wal-Mart Stores IncFEXOFENADINE HYDROCHLORIDE 30 mg/5mLJul 15, 2026Sep 2, 2026
Walgreens CompanyFEXOFENADINE HYDROCHLORIDE 30 mg/5mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Childrens Allergy — NDC 61269-0527-94," retrieved September 3, 2026, https://drugdashboards.com/drug/61269052794.

Free to cite with attribution — see how the data is put together.